港交所(00388.HK):上半年新股融資按年增近7倍
港交所(00388.HK)發佈香港股權融資市場2025年上半年回顧。根據數據供應商Dealogic的統計,上半年香港新股融資額達到141億美元,按年增長6.95倍,遠超全球新股融資額8%的增幅。
港交所指出,上半年投資者情緒回暖,同時大量優質公司通過香港市場籌集資金,推動香港股權融資市場大幅增長。儘管全球地緣政治環境仍然複雜,恆生指數期內領跑全球,上漲超過20%,港股平均每日成交金額按年增長82%,至2,400億元。
期內,隨着工業、消費、醫療保健、TMT(科技、媒體及電訊)、金融等各行各業公司來港上市,上半年的香港新股融資額已超過2022、2023及2024年每一年的全年水平。
港交所指,7月以來,香港新股市場延續上半年的強勁勢頭,7月首兩週已有8家公司成功上市。目前等候上市的公司仍然絡繹不絕,進一步鞏固了香港全球領先新股融資中心的地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.